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Abstract
Background: By allowing intercellular communication between cells, tunneling nanotubes (TNTs) could play critical
role in cancer progression. If TNT formation is known to require cytoskeleton remodeling, key mechanism
controlling their formation remains poorly understood.
Methods: The cells of human bronchial (HBEC-3, A549) or mesothelial (H2452, H28) lines are transfected with
different siRNAs (inactive, anti-RASSF1A, anti-GEFH1 and / or anti-Rab11). At 48 h post-transfection, i) the number
and length of the nanotubes per cell are quantified, ii) the organelles, previously labeled with specific tracers,
exchanged via these structures are monitored in real time between cells cultured in 2D or 3D and in normoxia,
hypoxia or in serum deprivation condition.
Results: We report that RASSF1A, a key-regulator of cytoskeleton encoded by a tumor-suppressor gene on 3p
chromosome, is involved in TNTs formation in bronchial and pleural cells since controlling proper activity of RhoB
guanine nucleotide exchange factor, GEF-H1. Indeed, the GEF-H1 inactivation induced by RASSF1A silencing, leads
to Rab11 accumulation and subsequent exosome releasing, which in turn contribute to TNTs formation. Finally, we
provide evidence involving TNT formation in bronchial carcinogenesis, by reporting that hypoxia or nutriment
privation, two almost universal conditions in human cancers, fail to prevent TNTs induced by the oncogenic
RASSF1A loss of expression.
Conclusions: This finding suggests for the first time that loss of RASSF1A expression could be a potential
biomarker for TNTs formation, such TNTs facilitating intercellular communication favoring multistep progression of
bronchial epithelial cells toward overt malignancy.
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Background
The tumor suppressor gene RASSF1 (Ras-association
domain family isoform) encodes one of the epithelial
phenotype guardians [25], RASSF1A, a scaffold protein
that maintains cellular homeostasis through control of
apoptosis, cell cycle, microtubules stabilization [5, 24,
60] and actin cytoskeleton organization [17, 25].
RASSF1A silencing is a frequent and early event in nu-
merous cancer including lung carcinoma [3, 19] and
malignant mesothelioma [22, 74]. In Non-Small Cell
Lung Cancer (NSCLC), RASSF1A inactivation is also
an independent marker of poor prognosis [19].
RASSF1A depletion underlies tumor initiation and pro-
gression [18] since inducing epithelial to mesenchymal
transition (EMT) in human bronchial cell lines with a
pro-metastatic phenotype sustained by both i) guanine
nucleotide exchange factor 1 (GEF-H1) inactivation and
subsequent RhoB (a putative anti-metastatic small
GTPase) inactivation and ii) nuclear accumulation of
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the active form of the Hippo pathway transcriptional
cofactor YAP (Yes-associated protein) [25].
Among long and narrow cytoplasmic extensions in-
duced by RASSF1A depletion, some did not seem to
contact the substratum [25], which distinguish these
structures from mesenchymal morphology or other cell
extensions such as filopodia [14]. As previously de-
scribed in others cell types (see review by Gerdes et al.
[27]), these structures reflect a defining characteristic
of tunneling nanotubes (TNTs) [62]. It is of note that
even TNTs and filopodia share structural similarities,
they are different cellular organization that form
through different mechanisms [20]. Further, TNTs are
divided in two subtypes: Type1 TNT (TNT-1) contain-
ing actin and tubulin filaments with a clear cytosolic
tunnel that can reach the distances of up to at least
70 μm [28], while Type2 TNT is shorter and contains
only actin filaments with unclear cytosolic tunnel. The
data in the literature suggest that these two types of
TNT could have different functions, as large material
(e.g., lysosomes, mitochondria) can only travel between
cells via TNT-1 on microtubules [9, 50, 76, 81].
TNT formation has been described as a result of ei-
ther directed filopodia-like protrusions or from cell dis-
lodgement mechanism [28], although, the molecular
basis of their formation still remains under active inves-
tigation. To date, actin and its associated proteins such
as myosin, small GTPase RalA, filamin, M-Sec and
Cdc42 are considered important regulators of TNT for-
mation in various cells, at least in part, through recruit-
ment of exocyst complex to the plasma membrane [12,
29, 33, 64]. In addition, p53 and the PI3K/AKT/mTOR
signaling pathways have been demonstrated to be in-
volved in stress-induced TNT formation [80]. Interest-
ingly, EMT was shown to stimulate TNT formation
[42]. Finally, the alteration of cell-cell junctions, which
occurs after RASSF1A depletion [25, 78] or the disrup-
tion of gap junction upon EMT [36], is thought to sup-
port the intercellular communication via TNTs [2].
In contrast to gap junctions or micro-vesicles that are
most effective in cell communication between relatively
close cells, TNTs have been proposed to connect cells lo-
cated far from each other [41]. TNTs are thus an emerging
mode of intercellular communication between cells at both
close and distant proximity, already known to facilitate dir-
ect transfer of cytosolic molecules and organelles, as well as
viral and microbial pathogens from cell to cell [49, 58, 62,
67]. In this respect, TNTs are potential candidates in facili-
tating the intracellular communication within the heteroge-
neous tumor microenvironment and have been proposed
to be involved in carcinogenesis initiation or later on, in
tumor progression [11, 37, 61]. Concordantly, TNTs were
identified in different solid resected tumors from patients
[76] especially in lung adenocarcinoma and mesothelioma
patients [2, 41]. The authors postulate that a higher rate of
formation of TNTs is associated with a higher level of local
invasion of tumors [2]. Moreover, the transfer of mitochon-
dria via TNT have been shown to enhance
chemo-resistance between cancer cell populations [54]. It
was also reported that TNT facilitate the exchange of nu-
cleic acid such as mRNA molecules, which could induce or
repress the transcription of genes implicated in cancer cell
motility or even enhance the transformation of normal
neighbor cells [31].
In this regard and given the role of RASSF1A in mi-
crotubules stabilization, actin organization and mainten-
ance of epithelial phenotype, we sought to determine
how depletion of RASSF1A could affect TNTs forma-
tion. We used a various panel of lung epithelial and
mesothelial cell lines to study the relation between
RASSF1A gene methylation and TNT formation at the
initial events leading to bronchial carcinogenesis, as well
as in malignant pleural mesothelioma. We employed
RASSF1A specific RNAi or a wild-type RASSF1A encod-
ing expression plasmid to assess the consequence of
RASSF1A depletion or rescuing on TNTs formation.
The role of cellular stressor such as hypoxia or serum
starvation has also been explored to recapitulate in vivo
cancer microenvironment conditions. Furthermore, we
looked for additional key proteins, which are perturbed
by loss of RASSF1A and could play a role in TNT for-
mation. These experiments reveal the role of RASSF1A/
GEFH1 signaling as a novel signaling module candidate
required for TNTs formation, through control of Rab11
accumulation and subsequent exosome release.
Methods
Cell culture and treatments
Isogenic HBEC-3 and HBEC-3-KRasV12 bronchial epi-
thelial cell lines were a generous gift of Dr. White (UT
Southwestern Medical Center, Dallas, USA) and were
cultured in KFSM (Keratinocyte-serum-free medium)
complemented with 0.2 ng/ml of human recombinant
EGF (Epidermal Growth Factor) and 25 μg/ml of BPE
(Bovine Pituitary Extract) supplements (Thermo Fisher
Scientific, Rockford, IL). The other cell lines lines were
purchased from ATCC. The tumorigenic epithelial cell
lines BEAS-2B, BEAS-2B-RasV12, H1975, A549, H1650,
H23, and H441 were cultured in DMEM (Dulbecco’s
modified essential medium; Gibco), while the mesothe-
lial H2452, H2052, H28 and MSTO-211H cell lines were
cultured in RPMI-1640 (Roswell Park Memorial Insti-
tute) medium (Invitrogen, Carlsbad, CA) supplemented
both with 2 mM of L-glutamine. All the mediums were
also complemented with 10% (vol/vol) heat-inactivated
fetal bovine serum, 100 U/ml penicillin, 100 μg/ml
streptomycin (Gibco). The cultures were incubated at
37 °C in a humidified atmosphere with 5% CO2. Where
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indicated, cells were treated for 24 h before fixation with
either paclitaxel (10 nM) to induce microtubule
stabilization, nocodazole (10 μM) to induce microtubule
depolymerization or blebbistatin (5 μM) to inhibit
myosin-II ATPase. To study the influence of metabolic
stress, cells were starved in a low-serum medium (0.5%
of FBS) for 24 h. Cells were placed in a hypoxic chamber
containing 0.1% oxygen, 5% carbon dioxide, and 93% ni-
trogen for 24 h to determine the influence of environ-
mental stress.
RNAi, plasmids and transfection procedures
RNAi treatment was performed at 30% confluence, using
Lipofectamine RNAiMAX (Invitrogen, Carlsbad, CA)
according to the manufacturer’s instructions and
analyzed 72 h after treatment. The following RNAi oli-
gonucleotides from Eurogentec® were used: RASSF1A:
si1: 5′-GACCUCUGUGGCGACUUCATT-3′ [66] & si2:
GAACGUGGACGAGCCUGU [25]; GEFH1: 5′-GAAG
GUAGCAGCCGUCUGU-3′ [25]; Rab11a: 5′-UGUC
AGACAGA CGCGAAAA-3′ [52]; Rab11b: 5′-GCAC
CUGACCUAUGAGAAC-3′ [52]; Vimentin: 5′-UCAC
GAUGACCUUGAAUAA-3′ [57] and non-targeting con-
trol RNAi from Dharmacon. Transient transfection with
plasmids encoding wild-type RASSF1A (pcDNA3-R-
ASSF1A) and control mimic (Addgene®) were performed
using Lipofectamine RNAiMAX (Invitrogen, Carlsbad,
CA) following the manufacturer’s instructions and ana-
lyzed 24 h after transfection.
RT-PCR
The mRNA expression was assayed using RT2 ProfilerTM
Cell motility PCR Array (Qiagen). Briefly, RNA isolated
from HBEC-3 cells transfected with siRASSF1A or siNeg
was reverse transcribed and relative gene expression data
was obtained using the Human Cell motility PCR Arrays.
The expression profile of 84 genes relevant to cell motility
as well as five housekeeping genes was assayed. Fold
change calculations were done using SABiosciences’ data
analysis software which automatically calculates the fold
change in gene expression between the treated and con-
trol groups.
Western blot analysis
Protein extraction were performed using a lysis buffer
consisting 20 mM Tris (pH 7.0), 50 mM NaCl, 20% gly-
cerol, 5 mM EDTA, and 0.1% TritonX100, 1 mM DTT,
50 mM 2-Mercaptoethanol and 1 μg/ml protease inhibitor
(aprotinin, leupeptin, pepstatin A, antipain). Proteins were
quantified using Bradford protein assay reagent and stored
at − 20 °C. After denaturation (5 min at 95 °C), cell lysates
were electrophoresed through SDS polyacrylamide gels,
and transferred to nitrocellulose membranes (Hybon-
d-ECL Amersham®). Non-specific sites were blocked for
1 h with Tris-buffered saline containing 0.1% Tween-20
(TBST) and 5% (w/v) non-fat milk. Membranes were
probed overnight with the primary antibody diluted at
1:1000 at 4 °C, and then 1 h at room temperature with the
appropriate horseradish peroxidase-linked secondary anti-
body diluted at 1:2000 in TBST/5%milk. Proteins detected
using an enhanced chemiluminescense technique with
ECL kit (Promega®).
Cell labelling and microscopy
Labelling of TNT with Alexa 488-WGA
As previously described [9], living cells were labelled
with at 5 μg/ml Alexa 488-conjugated WGA (Invitrogen)
for 10 min at 37 °C in the CO2 incubator. For structural
studies, cells were fixed in 4% paraformaldehyde for
5 min and observed in ProLong Gold antifade reagent
mounting medium (Invitrogen).
Labelling of protein
The primary antibodies used in this study are as follows:
anti-RASSF1A (eB114-10H1) from eBioscience, anti-
α-tubulin from Sigma Aldrich (St. Louis, MO) and anti-
β-actin (8H10D10), anti-cofilin (D3F9), anti-GEF-H1,
anti-HIF-1α, and anti-Rab11 from Cell Signaling Tech-
nology (Danvers, MA). Briefly, cells were seeded on cov-
erslips at a density of 2 × 104 per well. After treatment,
coverslips were washed with phosphate-buffered saline
PBS and fixed with 4% paraformaldehyde for 20 min at
37 °C. Cells were permeabilized using ice-cold methanol
for 10 min at − 20 °C to preserve microtubules. After
extensive washes with PBS, cells were blocked overnight
with 5% bovine serum albumin and then stained with
primary antibodies and counterstained with appropriate
Alexa Fluor 488-, and 555-conjugated secondary
antibodies (Thermo Fisher Scientific, Rockford, IL). Cover-
slips were mounted with DAPI (Santa Cruz Biotechnology),
and image captured with high-throughput confocal micros-
copy (FluoView FV1000, Olympus).
Organelle tracker analysis
To determine whether the TNTs allow the transport of
mitochondria, transfected cells were divided in two
groups. Each group were labeled separately by either
Green or Red MitoTracker dyes (Molecular Probes) for
30 min and then washed extensively with PBS before
mixing the two populations in the same culture dish.
After 1 h of incubation, the cells were either fixed or
subjected to the time-lapse imaging. We quantified the
number of cells that contain both Mitotracker (yellow
color).
To investigate the transfer of either lysosome or endo-
plasmic reticulum between the cells, Lyso Tracker™ or ER
tracker ™ (cell signaling) were added directly into normal
growth media for a working concentration of 50 nM or
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2 μM respectively according to the manufactures structures
and then analyzed immediately by real-time acquisition.
Confocal imaging
For living cells, the real-time acquisitions were per-
formed using an inverted microscope (Leica DMi8). The
microscopes were enclosed in environmental chambers
(Incubator i8) that were maintained at 37 °C with 5%
CO2 level. The Metamorph 7.8.13.0 software used for
image acquisition took a snapshot of four different ob-
servation fields every minute for 1 to 3 h. The acquired
images were then analyzed with the ImageJ software
(version 1.50d).
For fixed cells, images were captured with high-
throughput confocal microscopy (FluoView FV1000,
Olympus™).
gCW STED imaging
Image acquisitions were performed with a 100× oil
immersion objective (NA 1.4) through gCW STED im-
aging (TCS SP5-X; Leica Microsystems) with optimised
parameters for Alexa-488 detection. Samples (zoom 8,
pixel size = 18.95 nm) were excited with a 488 nm
wavelength of a supercontinuum laser. For fixed cells,
20–30% AOTF, conventional scanner (400 Hz, Line
Average 1, Accumulation 3, 1024 × 1024) and a step size
(0.13 μm) in the xyz mode were used. For living cells, 40–
80% AOTF, a resonant scanner (8000 Hz, 1024 × 1024)
and a step size (0.13 μm) in the xyz mode were used. De-
pletion was obtained with a 592 nm laser (70% AOTF).
Fluorescence (500–550 nm) was collected with a hybrid
detector (Gain 100) in the gated mode and a pinhole for
Airy 1. The temperature of the chamber was kept at 37 °
C, and cells were provided with constant gas flow (95%
O2, 5% CO2) during acquisition with living cells.
TNTs quantification
After immunolabeling of actin or tubulin filaments,
the cells were carefully analyzed for the presence of
TNTs, taking into account the criteria previously de-
scribed in the literature [43]. Those parameters in-
cluded (a) lack of adhesion of TNT to the substratum
of tissue culture plates (b) the width of the extension
estimated more than 1 μm and (c) a narrow base at
the base of TNT with a triangular aspect called “in
arrow”. The number of TNTs for each cell line or
after each treatment were counted in 10 randomly
chosen fields with 20× objective, and the TNT index
was calculated as the average number of TNTs per
cell. The TNT lengths were quantified using ImageJ
(version 1.50d).
3D collagen matrices preparation
Briefly, acid soluble collagen (Nutragen) was brought
to physiologic pH on ice to a final concentration of
4 mg/mL. The first layer of the cold collagen solution
was then pipetted (100 μL) onto a MatTek dishes
(MatTek Co., Ashand, MA) and were then warmed
into 37 °C in a cell culture incubator to allow colla-
gen polymerization for at least 30 min. During the
time of polymerization, the cells were resuspended in
cell culture medium. 2 × 105 cells were added on top
of the polymerized collagen layer and placed at 37 °C
incubator to allow attachment of the cells to collagen.
One hour later, the cells were coated with the second
layer of collagen (400 μL) for the establishment of 3D
microenvironnement. After 48 h, TNT was imaged
using time-lapse microscopy.
Electron microscopy
Transmission
Cells were rinsed in PBS Buffer, fixed with 2.5% glu-
taraldehyde in phosphate buffer 0.1 M pH 7.4 during
1 h at 4 °C, then rinsed in phosphate buffer 0.1 M
pH 7.4 and post-fixed 1 h with 1% osmium tetroxide
in phosphate buffer 0.1 M pH 7.4 (at 4 °C protected
from light). After washing, cells were dehydrated in
progressive bath of ethanol (70–100%), embedded in
resin Epon and polymerized 24 h at 60 °C. Ultrathin
sections were done and contrasted with uranyl acetate
and lead citrate. The cells were observed with trans-
mission electron microscope JEOL 1011 and image
were taken with Camera Gatan Orius 200 and digital
micrograph software. The number of vesicles was
quantified by counting the vesicles present for each
treatment condition in 10 fields taken from 10 dis-
tinct cells. The diameter of all these vesicles was
measured using the digital micrograph software linked
to the electron microscope.
Scanning
Cells, seeded on coverslips, are fixed with 2.5% glutaral-
dehyde overnight. The coverslips then undergo three
rinses of 10 min with the sodium cacodylate buffer solu-
tion pH 7.4 at 0.1 M. The samples are then dehydrated
with successive alcohol baths at 70, 95 and 100%, three
times 10 min each. A final bath of absolute alcohol will
be carried out in the critical point apparatus. A critical
point apparatus (Leica CPD 030) is used to replace the
alcohol with liquid CO2 in the cells. After bypassing the
critical point of CO2 (31 °C and 73 atm), there is a tran-
sition from the liquid state to the gaseous state. This
technique preserves the surface structure of the samples.
The CO2 gas is then gently removed and the samples
are brought back to room temperature.
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The lamellae are glued to a metal plate covered with
conductive tape. The samples are then covered with a
thin layer of platinum using a dedicated device (JFC1300
JEOL).
Exosome vesicles quantification
Exosome vesicles released into the culture medium were
assayed following the EXOCET kit (exosome quantita-
tion assay kit) and ExoQuick-TC procedures. Cell media
were centrifuged at 3000 × g for 15 min to remove any
cell debris. The supernatant (5 ml) were transferred to a
sterile container, to which 1 ml of ExoQuick-TC was
added. The mixed solution was incubated at 4 °C over-
night and then centrifuged at 1500 × g for 5 min. The
pellet was resuspended in 1 ml of PBS. An aliquot of the
suspension (20 μL) was mixed with 80 μL of Exosome
Lysis Buffer then was incubated at 37 °C for 5 min to
release the exosome proteins, vortexed 15 s and centri-
fuged 1500 × g for 5 min to remove debris. Supernatants
were transferred into a 96-well plate well to which are
added 50 μl of a mixture 1:1 of the EXOCET reaction
buffer reagents A and B before being incubated at room
temperature for 20 min. Absorbance at 405 nm was read
using a spectrophotometer.
Statistical analysis
Data are represented as the mean ± SEM of experiments
performed independently at least three times. To deter-
mine statistical significance, a Student’s unpaired t test
was applied to all experiments. Statistical significance
was set at p < 0.05.
Results
Characterization of the TNTs structure, formation and
intercellular exchange in bronchial or mesothelial cells
lines
We first wonder whether the nanotubes were ob-
served in various human epithelial bronchial or meso-
thelial cells lines, supporting their ubiquitous nature.
We cultured a panel of immortalized tumorigenic and
non-tumorigenic epithelial lung cell lines HBEC-3,
HBEC-3-RasV12, BEAS-2B, BEAS-2B-RasV12, lung
cancer cells lines H1975, A549, H1650, H23 and
H441, as well as mesothelioma cell lines H2452,
H2052, H28 and the immortalized MSTO-211H cells,
such cell lines being categorizing according their abil-
ity to express or not RASSF1A, depending on
RASSF1A gene methylation status (Additional file 1:
Figure S1A).The TNTs are considered not attached to
the substrate as they hover freely in medium and we
can observe the bodies of cells and the middle of
TNTs in two different optical sections and not with
the same focus through microscope [2, 9, 41]. To en-
sure that it is the case, we either used the time laps
(we thus can see that TNTs are even capable of pass-
ing above the other attached cells as showed on Add-
itional file 2: Movie S1) or observed TNTs on fixed
cells with confocal microscope and not with an epi-
fluorescence microscope to allow discrimination of
cells extension touching the substrates from cell
bridge (Additional file 3: Movie S2). We report that
each cell type exhibited TNTs independently of their
genetic background or their tumorigenicity. As illus-
trated, for one epithelial lung cell line, HBEC-3, and
one mesothelial cell line, H28, the observed struc-
tures, displayed either the specific characteristics of
TNT-1 (type1) with the presence of actin and micro-
tubule structures (Fig. 1a) or filopodia-like TNT-2
(type2), which contains only actin filaments (Fig. 1b)
[9]. For more elucidation, we have performed the im-
munofluorescence experiments with Fascin antibody,
a known filopodia marker [77]. We have systematic-
ally observed the presence of fascin along actin fila-
ments through thin structure of filopodia (Additional
file 1: Figure S1B); however, the results with TNTs
remained more variable, where fascin has been de-
tected along TNT in some cells but not others (Add-
itional file 1: Figure S1C). These results are better
explained by the two different scenario of TNT formation
[1]. Accordingly, we postulate that fascin is present in
TNT when they are formed by “actin driven protrusion”,
while it is absence when the TNT are issued of “cell dis-
lodgement mechanism”.
For further extended demonstration of TNT membrane
and morphological structures, we used subsequently
STimulated Emission Depletion (STED) nanoscopy, which
provides higher lateral resolution. In this regard, the clear
cytosolic tunnel, with wider tip on donor cell side and
thinner end point on acceptor cell side, was confirmed in
TNT1 (Fig. 1c). A cytosolic tunnel was not distinguishable
in TNT2 (Fig. 1d), as previously reported [9]. To evaluate
TNT formation in a more physiologically relevant micro-
environment, the cells were seeded between two layers of
type I collagen matrices (see Methods), which has been re-
ported to induce a switch from a 2D to a 3D morphology
and to mimic in vivo cellular environment [7]. Conse-
quently, we further confirmed TNT formation in a 3D en-
vironment by staining the cells with Alexa 488-wheat
germ agglutinin (WGA) (Fig. 1e), a lectin commonly used
to stain TNTs [9, 54]. The use of scanning electron mi-
croscopy makes it possible to better assess the appearance
of TNT formation and its anchoring to the target cell for
H28 cells (Fig. 1f) such as HBEC-3 cells (Fig. 1g).
Finally, subsequent studies with time-lapse imaging
supported the intercellular communication between cul-
tured HBEC-3 cells via TNT-1 (Additional file 4:
Movie S3), as it was also observed by transport of vital
mitochondrial dye (MitoTracker) along TNTs in
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Fig. 1 (See legend on next page.)
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HBEC-3 (Fig. 1h) as H28 (Fig. 1i). The functional activity
of TNTs was further reinforced upon transfer of vesicles
along TNT-1 using lysosome (LysoTracker, Additional
file 1: Figure S1D and Additional file 5: Movie S4) and
endoplasmic reticulum (ER-Tracker, Additional file 1:
Figure S1E) fluorescent dyes.
RASSF1A decreases overall TNTs number and length
As RASSF1A was shown to modulate both tubulin- and
actin- related structures [16, 25, 40], we then looked for
the role of RASSF1A in TNTs formation. We predomin-
antly focused on TNT-1 as they are responsible for the
transfer of materials between the cells [50, 81]. We report
that all RASSF1A-depleted cell lines (Additional file 6:
Table S1) except one, displayed significantly higher num-
ber of TNT-1 as compared to the cells with normal basal
RASSF1A expression (Fig. 2A-B and Additional file 1:
Figure S2A). There was only one exception for the H1975
cell line which exhibited numerous numbers of TNT-1
structures despite a wild type RASSF1A expression
(Fig. 2A and Additional file 1: Figure S1A).
To confirm whether influencing RASSF1A expression
in vitro could also modulate the occurrence of TNTs
formation, RASSF1A knockdown or re-expression was
achieved, respectively, in two cell lines with wild type ex-
pression of RASSF1A (HBEC-3 and H2452), and two
other cell lines (H28 and A549), which RASSF1A epi-
genetic silencing (Additional file 1: Figure S1A and Add-
itional file 6: Table S1). We observed that extinction of
RASSF1A expression in non-tumorigenic HBEC-3 cells,
using two different RNA interference [25] (Additional
file 1: Figure S2B), increased the average number of
TNT-1 per cell (2-fold, p < 0.01, Fig. 2C & E and
Additional file 1: Figure S2C), as compared to the cells
treated with control RNAi. Besides, after RASSF1A de-
pletion, the mean cell-to-cell length of TNT-1 was 1.5
fold higher and could reach up to about 250 μm in
length, while control HBEC-3 cells transfected with
non-relevant siRNA exhibited TNT-1 reaching not more
than 170 μm in length (p < 0.01, Fig. 2D-E). For clarity,
only the data with one RASSF1A RNAi is shown. The
same result was also observed in malignant mesotheli-
oma H2452 cells line after RASSF1A depletion
(Additional file 1: Figure S2D, Fig. 2F).
Next, we investigated whether RASSF1A depletion was
able to induce functional TNT-1, which allow long dis-
tance communication between cells. In this regard, trans-
fected cells were divided in two groups. Each group were
labeled separately by either Green or Red MitoTracker
dyes (Molecular Probes) before being reseeded together.
Time lapse imaging of siNeg or siRASSF1A treated
HBEC-3 cells revealed the enhanced transfer of mitochon-
dria after RASSF1A depletion, quantified by cells which
contain double labeled MitoTracker dye (Fig. 2G-H).
Interestingly, intercellular transfers of cytoplasmic content
through TNT-1 occurred similarly between the co-culture
of RASSF1A-depleted HBEC-3 cells with different cell
line, as shown with the Mitotracker labeled epithelial
BEAS-2B cells or mesothelial H28 cells and even healthy
lung fibroblast cells (Fig. 2I).
Concordantly, transfection of the plasmid encoding wild
type RASSF1A in malignant mesothelioma H28 cell line
and lung epithelial A549 (Additional file 1: Figure S2F),
decreased significantly not only TNT-1 formation, but
also their length and intracellular transfers of mitochon-
dria, compared to the cells transfected with the control
plasmid (Fig. 2J-N and Additional file 1: Figure S2E).
Taken together, these data provide evidence of the role of
RASSF1A in TNTs formation and support the existence
of a specific signaling pathway, which leads to an increase
of functional TNT-1 after RASSF1A depletion.
RASSF1A knockdown increases TNTs formation in either
hypoxic or serum starved conditions
Environmental or metabolic stresses, such as hypoxia or
nutriment starvation, are characteristic of the aggressive
tumor microenvironment and have been identified as a
hallmark of malignant tumors [63, 85]. The lack of oxy-
gen or nutriments is known to stimulate TNTs forma-
tion that serves as an adaptive response to facilitate the
connection of the cells at the long distance for the ex-
change of cytoplasmic materials in order to survive in
such hostile conditions [21, 41, 80]. To investigate
whether RASSF1A depletion could still enhance TNT-1
occurrence in these conditions, 48 h after transfection,
the HBEC-3 cell lines were exposed for another 24 h to
either hypoxic environment with 0.1% oxygen or starved
in a low-serum medium (0.5% FBS).
(See figure on previous page.)
Fig. 1 Bronchial as mesothelial cells establish both TNT1 and TNT2 and transfer mitochondria to other cells along TNT1. a–b Representative
images of cytoskeletal elements presented in either TNT1 or TNT2. HBEC-3 and H28 cells were fixed and labelled with actin (green) and tubulin
(red). Boxed regions were used for the zoom of each channel. c–d Structural analysis of TNTs subtypes in HBEC-3 and H28 cells through
deconvoluted gCW STED nanoscopy. The cells were fixed and stained with Phalloidin for actin filaments. Arrowheads indicate the TNT2. e
Representative image of TNT between HBEC-3 cells cultivated in 3D collagen matrix along with an optical sections reconstructed in three
dimensions. f–g Representative image of TNT between H28 (f) and HBEC-3 (g) using scanning electron microscopy. h–i Montage of MitoTracker
dye movement (arrow heads) along TNT in live HBEC-3 (h) and H28 (i) cells using time-lapse fluorescence video microscopy. Cells were imaged
every min for 1 h. See Methods for protocol details
Dubois et al. Cell Communication and Signaling  (2018) 16:66 Page 7 of 20
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To confirm the oxygen deprivation in culture, hypoxia
inducible factor-1α (HIF-1α) expression was examined
by immunofluorescence in the cells exposed to either
normoxic or hypoxic conditions, since HIF-1α is known
to maintain cellular homeostasis in low oxygen levels
and thus can serve as an effective molecular marker of
hypoxia [79]. We actually found a nuclear HIF-1α signal
in HBEC-3 cell in hypoxic culture condition as com-
pared to the cells cultured in normoxic condition, in
which no HIF-1α signal was detected (Fig. 3A). The ef-
fect of serum deprivation is also confirmed by the in-
crease of altered-nucleus cells after DAPI staining
compared to control cells with intact nuclei (Fig. 3B).
As stated earlier in the cells cultured in standard
medium conditions (10% fetal bovine serum and nor-
moxic environment), RASSF1A depletion did increase
the number of TNT-1. In either hypoxic environment or
in the cells exposed to serum deprivation, RASSF1A de-
pletion still enhanced significantly TNT-1 formation
compared to the cells transfected with control RNAi
(Fig. 3C-D). These data suggest that RASSF1A promoter
methylation, observed at the early pre-invasive stage of
cancer development [19], may actually be beneficial for
cell survival during environmental or metabolic stresses.
Vimentin and actomyosin are needed for TNTs formation
after RASSF1A depletion
We then sought to determine whether RASSF1A deple-
tion increased the number and length of the functional
TNTs by influencing cytoskeletal elements. Indeed, in
line with the role of RASSF1A in maintaining epithelial
phenotype [25], increase of vimentin expression (marker
of mesenchymal cells [44]) in RASSF1A depleted
HBEC-3 epithelial cells was concordant with the in-
crease of TNT-1 formation (Fig. 4A-B), while RASSF1A
re-expression in A549 cells, significantly reduced both
vimentin and TNT-1 number (Fig. 4C-D). Similarly, de-
pletion of vimentin by RNAi, decreased significantly the
ability of RASSF1A-knockdown cells to form TNT-1
(Fig. 4E-F). These observations suggest a role for vimen-
tin in TNTs genesis.
We also sought to study the role of other cytoskeletal
components, and 48 h after RASSF1A knockdown,
HBEC-3 cells were incubated with cytoskeleton disrupt-
ing drugs during 24 h, before fixation. Despite the
well-known role of RASSF1A in microtubules
stabilization [16, 26], stabilization of the microtubule by
paclitaxel (10 nM) or their depolymerization with noco-
dazole (10 μM) did not affect the enhancement of
TNT-1 formation induced by RASSF1A knockdown
(Fig. 4G-H). In contrast, inhibition of myosin II ATPase
with blebbistatin (5 μM) increased not only the TNT-1
formation in control cells, but also showed an additive
effect with RASSF1A depletion on enhancement of
TNT-1 genesis (Fig. 4G-H). We also find that RASSF1A
knockdown reduced the mRNA expression of Myosin 9
and 10 heavy chains mRNAs and increased the expres-
sion of Myosin 9 light chain transcript (Fig. 4I). These
data confirm the previously identified role of the loss
actin bundles in TNTs formation [30, 51], while con-
versely supporting a new role for RASSF1A as a modula-
tor of TNTs formation, through control of myosin
expression and actin filaments contractility.
Exosomes released by RASS1A depleted cells affect TNT
formation
To gain further insight in the singular role of RASSF1A
depletion on TNTs formation, we investigated how
TNTs formation was triggered. Recently, vesicles from
exosomes were also determined as mediators of TNTs
formation in mesothelioma cells [71]. Interestingly, our
preliminary observations also revealed the presence of
multiple vesicles-like structures in the cytoplasm of
RASSF1A-knockdown cells (Additional file 7: Movie S5).
A closer look on the images captured by electron mi-
croscopy (Fig. 5a), confirmed that RASSF1A depletion
did increase the number of vesicles (Fig. 5b), without af-
fecting their diameters (Fig. 5c). To our surprise, the
(See figure on previous page.)
Fig. 2 RASSF1A expression decreases overall TNT number and length. (a) Quantitative description of the average number of TNTs established for
each cell line. TNT’s number was classified as low (+), moderate (++) or high (+++) if there were observed ≤1, 1≤ 3 or > 3 TNT per cell
respectively. (b) Representative images of TNT in HBEC-3, A549 and H28 cell lines fixed and stained with tubulin. (c) Quantification of the TNT
number and (d) length (μm) in HBEC-3 cell line along with (e) representative images (ei, eii and eiii are zoom of the corresponding arrowheads).
The HBEC-3 cells were treated with control or RASSF1A RNAi as indicated. Western blot showing the efficiency of RASSF1A depletion in HBEC-3
cells 72 h after RNAi treatment. Arrowheads indicate the TNTs. Roman numerals mark the examples of the TNT in the zoomed images. (f)
Representative image of TNT between H2452 expressing or not (siRASSF1A) RASSF1A using scanning electron microscopy (g) Quantification and
(h) representative images of HBEC-3 cells contained both green and red MitoTracker dyes after RNAi treatment as indicated. (i) Representative
images of the double labeled MitoTracker dyes in co-culture of RASSF1A-depleted HBEC-3 cells with BEAS-2B, H28 or healthy lung fibroblast cells
(j) Quantification of the TNT number and (k) length (μm) in H28 cell line along with (l) representative images (li, lii and liii are zoom of the
corresponding arrowheads). The H28 cells were transfected with construct encoding wild-type RASSF1A as indicated. The TNTs are show with
arrowheads. Western blot showing the efficiency of RASSF1A transfection in H28 cells 24 h after treatment. (m) Quantification and (n)
representative images of H28 cells contained both green and red MitoTracker dyes after pcDNA transfection as indicated. Values are the mean ±
SEM of three independent experiments in almost 200 cells. Statistical significance was calculated and p value are indicated by asterisks: *p < 0,05.
See Methods for quantification details of each experiments
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quantification of the exosome released in culture media
by RASSF1A knockdown cells did not differ from the
control cells (Fig. 5d). Therefore, we postulated that exo-
some production and content might be influenced by
RASSF1A expression. In line with this hypothesis, the im-
munofluorescence staining of cofilin, a protein implicated
in exosome biogenesis and function [73], confirmed a
clear increase in cofilin content within exosome structures
upon RASSF1A depletion (Fig. 5e).
To test whether the exosome contents can modulate
TNT-1 formation, 48 h after transfection, the medium
from siNeg- or siRASSF1A-transfected HBEC-3 cells
was collected and transferred to the parental non-treated
HBEC-3 cells. Remarkably, 24 h after medium transfer, we
Fig. 3 TNTs induced by RASSF1A depletion still occurs in either hypoxic or serum starved conditions. (a) Representative images of HIF-1α in
HBEC-3 cells incubated for 24 h in normoxic or hypoxic (0.1% O2) condition after transfection with either control or RASSF1A RNAi. (b)
Representative images of the increased number of multi-nucleus HBEC-3 cells, as the result of serum deprivation compared to the cells incubated
in normal condition with intact nuclei. (c) Quantification of TNT number in control and RASSF1A depleted HBEC-3 cells after incubation in either
hypoxic or serum starved conditions and (d) Representative images (i and ii are zoom of the corresponding arrowheads for respectively control
condition, hypoxia or deprivation treatment). The TNTs are show with arrowheads. Roman numerals mark the examples of the TNT in the
zoomed images. Values are the mean ± SEM of three independent experiments in approximately 200 cells. Statistical significance was calculated
and p value are indicated by asterisks: *p < 0.05, **p < 0,01; *** < 0,001
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noticed a significant increase of TNT-1 formation in
HBEC-3 cells incubated with the medium issued from
RASSF1A-depleted cells (Fig. 5f–g). This data reveals that
the increase of TNT-1 formation after RASSF1A depletion
could occur, at least in part, by the secretion-dependent
mechanisms and by the release of exocytic vesicles in the
extracellular medium.
TNTs formation induced by RASSF1A silencing
simultaneously depends on GEF-H1 inactivation and
Rab11 activation
Next, we investigated which potential mechanistic path-
way was essential for TNTs formation in RASSF1A-de-
pleted cells. Recently, our group demonstrated that
RASSF1A depletion inhibits the anti-metastatic RhoB
GTPase via phosphorylation and inactivation of GEF-
H1, with potential implications to delay the progression
of RASSF1-hypermethylated lung tumors [25]. Interest-
ingly, GEF-H1 was also reported to be required for endocy-
tic and exocytic vesicle trafficking [56]. Therefore, we
wondered whether the increase of TNT-1 formation in
RASSF1A-depleted cells was actually mediated by GEF-H1
inactivation.
In this respect, GEF-H1 inactivation was achieved by
siRNA in either HBEC-3 or H2452 cell lines with normal
RASSF1A basal expression (Additional file 1: Figure S3A-C).
In line with our hypothesis, in both cell types, GEF-H1 de-
pletion significantly elevated the TNT-1 formation in control
cells, comparable to the level of TNT-1 number in the cells
depleted for RASSF1A (Fig. 6a–b and Additional file 1:
Figure S3D-E). Therefore, these data support the idea that
the effect of RASSF1A could be mediated by GEF-H1
signaling.
Furthermore, it is known in the literature that loss of
GEF-H1 induces the accumulation of Rab11 [55], a small
GTPase regulating exocytosis at the plasma membrane
[70]. Rab11a and Rab11b are two closely related Rab11
isoforms, which are ubiquitously expressed in most tis-
sue [13]. Previously, Rab11a was also implicated in the
TNTs formation [86]. Accordingly, we observed in-
creased expression of Rab11a/b in the absence of
RASSF1A (Additional file 1: Figure S3F-G). In this con-
text, we aimed to determine if elevated amount of Rab11
was also involved in the induction of TNTs observed in
RASSF1A depleted cells. Hence, by using both Rab11a
and Rab11b RNAi in HBEC-3 and H2452 cell lines
(Additional file 1: Figure S2H-J), we observed that loss
of Rab11a or Rab11b induced a clear and significant re-
duction in the number of TNT-1 in RASSF1A-knock-
down cells, compared with cells treated with siRASSF1A
alone (Fig. 6c–d and Additional file 1: Figure S2K-L).
In addition, by quantifying mitochondria transfer be-
tween the cells, using MitoTracker, we tested whether al-
tering either GEF-H1 or Rab11 expression, coincided with
the modulation of functional TNTs formation, to allow
long distance cell-cell communication. Consistent with
above data, confocal and time-lapse imaging showed that
loss of GEF-H1 in HBEC-3 cell line, led to an increased
number of double positive cells, indicative of effective or-
ganelle transfer (Fig. 6e–f ). Conversely, double knock-
down of both RASSF1A and Rab11a, or Rab11b, which
decreased significantly the TNT-1 induction, repressed
the intercellular mitochondria transfer (Fig. 6g–h). It is of
note that the absence of double-labeled mitochondria in
individual cell, which did not show any contact via TNTs
during time-lapse imaging, argues against the passive dye
transfer between the cells. Overall, these results indicate
the role of GEF-H1/Rab11 signaling in association with
RASSF1A expression, in the control of intercellular com-
munication, by modulating TNTs formation.
Discussion
We previously showed that the loss of expression of the
tumor suppressor gene RASSF1A was a factor of poor
prognosis in patient with non-small cell lung cancer [19]
since the inactivation of RASSF1A, by altering both the
Hippo and Rho signaling pathways, led to the acquisition of
a metastatic phenotype by the tumor cells. Here, we hy-
pothesized that the RASSF1A knockdown could also affect
intercellular communication via tunneling nanotubes
(TNTs), since TNT-1 contains actin and microtubules [9],
two elements of the cytoskeleton influenced by RASSF1A
cell content [25]. With the present work, we now provide
evidence that RASSF1A, by controlling proper GEF-H1/
Rab11 activities and cytoskeleton architecture, also prevents
(See figure on previous page.)
Fig. 4 Vimentin and actomysoin are implicated in TNT formation after RASSF1A depletion. (a) Quantification and (b) representative images of
Vimentin expression in HBEC-3 cells transfected with siNEG or siRASSF1A. (c) Quantification and (d) representative images of Vimentin expression
in A549 cells transfected with pcDNA control or RASSF1A. (e) Quantification and (f) representative images of TNT formation in HBEC-3 cells
transfected with either siVimentin alone or in combination with siRASSF1A. (g) Representative images (i and ii are zoom of the corresponding
arrowheads for respectively DMSO, Paclitaxel, Nocodazole and Blebbistatin treatment) and (h) quantification of TNT number in control and
RASSF1A depleted HBEC-3 cells after incubation with paclitaxel (10 nM), nocodazole (10 μM) or blebbistatin (5 μM) for 24 h before fixation and
staining with α-tubulin. The TNTs are show with arrowheads. Roman numerals mark the examples of the TNT in the zoomed images. (c) The
mRNA expression was assayed using RT2 ProfilerTM Cell motility PCR Array (Qiagen). β2-microglobulin was used as an internal control. Values are
the mean ± SEM of three independent experiments in almost 200 cells. Statistical significance was calculated and p value are indicated by
asterisks: *p < 0.05, **p < 0.01, *** < 0.001
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TNTs formation in bronchial epithelial or pleural mesothe-
lial cells.
TNTs were first described in vitro in 2004 in the rat
pheochromocytoma PC12 cells [62], before being ob-
served in several other cell types (fibroblasts, epithelial
cells, immune cells, cardiomyocytes, hippocampal astro-
cytes, mesenchymal stem cells), as well as in primary
cancer cell lines (from ovarian, breast, pancreatic, pros-
tate or colon cancers) [41]. TNTs have then been
described ex-vivo in tumor samples from patients with
malignant pleural mesothelioma or lung adenocarcin-
oma [67]. Here, by using a panel of different lung epithe-
lial and mesothelioma cell lines, we confirm that TNTs
are ubiquitous cellular structures, since all the cell lines
studied displayed cell extensions with the specific char-
acteristics of TNTs (Fig. 1). We also observed that these
TNTs enhanced intercellular exchange, time-lapse im-
aging revealing the presence of organelles such as
Fig. 5 Exosomes released by RASSF1A depleted cells affect TNT formation. a Representative images and b–c quantification of cytoplasmic
vesicles number and diameter (μm) by electron microscopy in HBEC-3 cells after transfection with control or RASSF1A RNAi. The vesicles are
show with yellow arrowheads. d Quantification of the exosome release in control and RASSF1A knockdown HBEC-3 cells. e Representative
images of cofilin staining in cells transfected with RNAi as indicated. f Quantification and g representative images of the TNT formation in non-
treated HBEC-3 cells incubated with supernatant obtained from siNEG or siRASSF1A treated cells during 24 h. The TNTs are show with
arrowheads. Values are the mean ± SEM of three independent experiments in approximately 200 cells. Statistical significance was calculated and
p value are indicated by asterisks: **p < 0.01
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mitochondria, lysosome or endoplasmic reticulum along
TNTs going from one donor to one acceptor cell (Fig. 1
and Additional file 1: Figure S1).
The analysis of the different native lung epithelial and
mesothelioma cell lines, as the analysis of lung and
mesothelial cells upon RASSF1A silencing, or conversely
re-expression pointed out the preferential formation of
TNT-1 in RASSF1A-depleted cells, compared to cells
with normal RASSF1A expression (Fig. 2). Only H1975
cell line, despite a normal expression of RASSF1A, ex-
hibited numerous numbers of TNTs formation which
could be explained by the activating mutation of PI3K
on these cells [53], since PI3K was previously implicated
in TNTs induction [67, 80].
We demonstrate here that RASSF1A prevents TNT-1
by its control on both actin cytoarchitecture and inter-
mediate filaments components. Indeed, while micro-
tubule and actin are the main building blocks of TNTs
genesis and stabilization [27], we provide evidence that
TNT-1 induced by RASSF1A silencing in bronchial epi-
thelial or mesothelial cells did not depend on microtu-
bules since TNT-1 were insusceptible to either
pharmacologic stabilization of microtubules by paclitaxel
or further depolymerization by nocodazole (Fig. 4).
While some studies showed the involvement of the mi-
crotubules in the formation of TNTs [81], others did not
find such a role [39, 59], suggesting that the role of
microtubule in TNTs formation, may vary depending on
the cells type. Conversely, in line with previous reports,
we confirmed the involvements of actin, because the loss
of actomyosin filaments network induced by blebbistatin
treatment impaired TNTs formation in our cells [27, 30,
32, 51]. RASSF1A depletion enhanced synergistically the
effects of blebbistatin to drive extension of TNTs pro-
trusions (Fig. 4). Accordingly, RASSF1A depletion also
influenced different myosin’s chains expression. A poten-
tial explanation for these results might come from our
previous data where RASSF1A depletion was found to
influence actin structure through modulating both Rho
GTPase and LIMK/Cofilin signaling pathways [25, 68],
proteins largely linked to modulation of actomyosin as-
sembly [6, 83]. In addition, we revealed that increase of
intermediate filament vimentin, after acquisition of EMT
in RASSF1A depleted cells [25], might also contribute to
the TNTs formation. Few reports have characterized the
presence of intermediate filament such as vimentin along the
length of TNTs [2, 75]. Here, we confirmed not only the
presence of vimentin along TNTs, but also, we found out
that the increase of vimentin expression was concomitant
with TNTs formation while vimentin silencing by siRNA de-
creases TNT-1 formation (Fig. 4). Besides, it is of note that
EMT was shown to be a favorable factor to induce TNTs
formation [42].
The TNTs induced by the loss of RASSF1A in bronchial
epithelial or mesothelial cells are functional and allow the
exchange of organelles and in particular of mitochondrial,
lysosome or endoplasmic reticulum between cells (Fig. 2).
As RASSF1A methylation occurs at the early stage of nu-
merous human cancers and its inactivation is associated
with more aggressive tumor phenotype [23, 34], increase of
TNT-1 formation in the absence of RASSF1A, could act by
stimulating metabolic adaptation of cancer cells at the early
stage, and could further participate to the emergence of re-
sistance during drug treatment. Tumor microenvironment
is often hypoxic, inflammatory and nutrient-poor during
cancer growth. The transfer of different cytoplasmic com-
ponents including oncogenic genetic materials or nutrients,
via TNT-1 has already been suggested to be responsible for
the acquisition of functional benefits and phenotypic modi-
fications helping cell survival during environmental or
metabolic stresses [2], and even to be responsible for caus-
ing and/or maintaining drug resistance [4, 54]. For instance,
it has been shown that hypoxia can also induce
TNTs-mediated communication [21], and active transfers
of mitochondria through TNTs was suggested to rescue
aerobic respiration in cells with dysfunctional mitochondria
[69]. Importantly, increase of TNT-1 formation in the ab-
sence of RASSF1A still occur in either hypoxic or serum
starved conditions (Fig. 3). Further, an increased release of
exosome was found to be triggered by environmental or
metabolic stress [8, 38] as it was observed in a similar way
for TNTs formation [21, 41, 80].
Given the ability of RASSF1A to influence LIMK/Cofilin
activity [25] and the identified role of cofilin in exosome
release [84], another interesting insight was to explore the
simultaneous implication of both RASSF1A and exocyt-
osis in TNTs formation. We have observed that the
addition of the media issued from RASSF1A-depleted cells
was sufficient to enhance the TNT-1 formation in
non-treated cells (Fig. 5). Considering this result and in
line with previous reports [46, 48, 65], we postulated that
the increase of secretion or uptake of exosomes after
(See figure on previous page.)
Fig. 6 TNTs formation in the absence of RASSF1A is dependent on GEFH1 inactivation and Rab11 activation. a Quantification and b
representative images of the TNT formation in HBEC-3 cells transfected with siNEG or siRASSF1A in combination with siGEFH1. c Quantification
and d representative images of the TNT formation in HBEC-3 cells transfected with siNEG or siRASSF1A in combination with either siRab11a or
siRab11b. e and g Quantification and f and h representative images of HBEC-3 cells labeled with both green and red MitoTracker dyes after RNAi
treatment as indicated. Values are the mean ± SEM of three independent experiments in at least 200 cells. Statistical significance was determined
by Student’s t-test and p value are indicated by asterisks: *p < 0.05; **p < 0.01; ***p < 0.001. The TNTs are show with arrowheads
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RASSF1A knockdown could also be introduced as poten-
tial chemotactic stimuli acting as paracrine effectors to in-
duce TNT formation. They encapsulate the cytosol of the
producing cell containing various effector molecules such
as proteins and microRNAs as well as cytoskeleton com-
ponents including microtubule and actin binding proteins.
However, it is still not established whether exosome itself
or cytosolic signaling molecules carried within are respon-
sible for the role of exosomes in TNTs formation [35, 45,
72]. Moreover, we cannot completely exclude the possibil-
ity that secretion of cytokine and chemokine-based signal-
ing molecules, could act in concert with exosomes to
increase TNT formation. In this regard, it has also been
shown that TNT stimulate the secretion of prosurvival cy-
tokines [47]. In addition, exosomes are also able to affect
cytokines expression profiles [35, 82]. It is of note that
characterizing key players of the exosomes or other freely
diffusible signals in TNT formation is the main subject of
ongoing work in our laboratory.
Mechanistically, we finally demonstrate that RASSF1A
prevents TNTs by regulating both the cytoskeleton and
exocytosis, since controls proper GEF-H1 and Rab11 ac-
tivities. Our group has previously demonstrated that
RASSF1A knockdown can induce EMT and increase of
invasiveness, at least in part, through GEF-H1 inactiva-
tion [25]. Besides, it is known that GEF-H1 is a micro-
tubule binding protein, which can also influence the
dynamics of the actin filaments by modulating either
Rac or Rho activities [10]. Using confocal and time-lapse
imaging, we reported that GEF-H1 depletion actually in-
creased both TNTs formation and intercellular transfer
between the cells (Fig. 6). Accordingly, RalGPS2, an in-
dependent GEF for the Ral GTPase, was also shown to
promote the TNTs formation through rearrangement of
actin cytoskeleton in bladder cancer [15]. While previ-
ously described in Hela cells [55], we confirmed here in
bronchial epithelial or pleural mesothelial cells that
GEF-H1 depletion did induce Rab11 accumulation
(Additional file 1: Figure S3). However, from our results,
we suggest that GEF-H1 depletion increase exosome se-
cretion, whereas, Pathak et al., indicate a negative role
for GEH-H1 depletion in regulation of exocytosis. Two
different hypotheses have been put forward to reconcile
these disparate observations. The first, these conflicting
data may be explained by context-dependent expression
of GEF effectors or their modification. Indeed, the
GEF-H1 inactivation induced by RASSF1A silencing,
leads only to the decrease of RhoB expression and activity,
Fig. 7 RASSF1A prevents tunneling nanotube formation between cells through GEFH1/Rab11 pathway control
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without affecting RhoA levels [25]. On the contrary, the
former study show RhoA activation in response to
RalA-Sec5 signaling [55]. Alternatively, differences in cell
type or the experimental design in the two studies may be
another reason for the opposing results. On the other
hands, Rab11 knockdown in RASSF1A-depleted cells, ac-
tually decreased the induction of TNTs and subsequent
organelle transfer. In line with our results, a recent study
demonstrated that downregulation of Rab11 in Schwann
cells decreased the formation of functional TNTs and
vesicle transfer between the cells [86]. Thus, decrease of
GEF-H1 activity, in addition to Rab11 accumulation after
RASSF1A knockdown, induces the increase of TNTs for-
mation, possibly by altering exocytosis. In agreement with
the role of exocytosis in TNTs formation reported here
and by others [46, 65], it is interesting to note that accu-
mulation of Rab11 induced by GEF-H1 depletion [55, 56]
was previously shown to regulates exocytosis at the
plasma membrane [70].
Taken together, we provide evidence here that RASSF1A
depletion increased the number and length of functional
TNTs. It occurred mechanistically because of i) increase
of vimentin expression upon the induction of EMT ii) loss
of actomyosin network through modulating both Rho
GTPase and LIMK/Cofilin signaling pathways and iii)
control of exosome release possibly by inducing GEF-H1
inactivation and RAB11 upregulation (Fig. 7).
Conclusions
To our knowledge, this study represents the first evi-
dence for a role of RASSF1A in TNTs formation. Thus,
we postulate that RASSF1A methylation within the com-
plex and heterogeneous tumor microenvironment would
allow the cancer cells to transmit cytoplasmic compo-
nents (proteins and genetic material) over a long-range
distance through TNTs to neighbor cells. Accordingly,
targeting TNTs formation appears to consist of a prom-
ising therapeutic strategy for preventing development of
chemotherapy resistance cancer cells. However, further
in-depth preclinical and clinical studies are warranted to
investigate the physiologic impact of TNTs within the
tumor-stromal matrix and the role of RASSF1A alter-
ation in such phenomenon.
Additional files
Additional file 1: Figure S1. (A) RASSF1A expression in cell lines used
in this work by RT-PCR. (B-C) Representative fascin co-staining along actin
in both filopodia and TNTs. (D-E)Representative images of (D) Lysosome(-
LysoTracker) and (E) endoplasmic reticulum (ER-Tracker) along TNT in
HBEC-3 cells. Figure S2. RASSF1A expression modulates overall TNT num-
ber. (A) Representative images of TNT-1 in the cell lines, as indicated (B)
immunofluorescence quantification and images indicating a reduction of
RASSF1A expression after knockdown (C) Representative image of TNT-1
after RASSF1A depletion by siRASSF1A(2). (D) Quantification of the TNT
number along with representative images of siNeg or siRASSF1A trans-
fected H2452 cells. (E) Quantification of the TNT number in A549 cell line
along with representative images. The H28 cells were transfected with
construct encoding wild-type RASSF1A. Arrowheads indicate the TNTs.
Roman numerals mark the examples of the TNT in the zoomed images.
(F) Representative image of RASSF1A and actin immunostaining showing
the efficiency of pcRASSF1A transfection in RASSF1A-null H28 and A549
cells. Statistical significance was determined by Student’s ttest, p value
are indicated by asterisks (*p < 0.05). Figure S3. TNTs formation induced
by RASSF1A loss depends on GEFH1 inactivation and Rab11 activation.
(A-B) Immunofluorescence and (C) RT-PCR images showing the efficiency
of GEFH1 depletion (D) Quantification and (E) representative images of
the TNT formation in H2452 cells transfected with siNEG or siRASSF1A in
combination with siGEFH1. (F-G) Immunofluorescence images showing
the increase of Rab11 expression after RASSF1A depletion. (H) RT-PCR
and (I-J) Immunofluorescence images showing the efficiency of Rab11
depletion in cells 72 h after RNAi treatment. (K) Quantification and (L)
representative images of the TNT formation in H2452 cells transfected
with siNEG or siRASSF1A in combination with either siRab11a or siRab11b.
Values are the mean ± SEM (n≥3). Statistical significance was determined
by Student’s t-test, p value are indicated by asterisks (*p < 0.05;**p <
0.01;***p < 0.001). Arrowheads show TNTs. (PDF 3664 kb)
Additional file 2: Movie S1. TNTs are cell bridge capable of passing
above the other attached HBEC-3 cells. (AVI 561 kb)
Additional file 3: Movie S2. TNT-1 are cell bridge not touching the
substrate(here on H2452 cells). (AVI 464 kb)
Additional file 4: Movie S3. Intercellular communication between
cultured HBEC-3 cells via TNT-1. (AVI 768 kb)
Additional file 5: Movie S4. Transfer of vesicles along TNT-1 using
lysosome fluorecent dye in HBEC-3. (AVI 288 kb)
Additional file 6: Table S1. Characteristics of the cell lines used in the
study. (DOCX 20 kb)
Additional file 7: Movie S5. Multiple vesicles-like structures are present
in the cytoplasm of RASSF1A-knockdown cells. (AVI 936 kb)
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